Sistemik Ondansetron Kullanımının Subaraknoid Blok ... - TARD

A. Selçuk ve ark., Ondansetron ve Subaraknoid Blok
kısa bulunmuştur. Mowafi HA ve ark.’da
bizim gibi motor blok açısından gruplar
arasında fark bulamamıştır.
Sonuç olarak, her ne kadar çalışmamızda
subaraknoid enjeksiyon öncesi iv olarak
uygulanan ondansetron; bupivakain ve
fentanil kombinasyonu ile elde edilen spinal
blok parametrelerinden S2 regresyon
zamanı ve total anestezi süresini kısaltsa
da, ondansetronun diğer lokal anesteziklerle
ilişkisini ve antinosisepsiyon üzerine
kesin etki mekanizmasını belirlemek için
ileri çalışmalara gereksinim olduğunu düşünmekteyiz.
KAYNAKLAR
1. Fassoulaki A, Melemeni A, Zotou M, Sarantopoulos
C. Systemic ondansetron antagonizes the
sensory block produced by intrathecal lidocaine.
Anesth Analg 2005;100:1817-21.
2. Kelsaka E, Baris S, Karakaya D, Sarihasan B.
Comparison of ondansetron and meperidine
for prevention of shivering in patients undergoing
spinal anesthesia. Reg Anesth Pain Med
2006;31:40-5.
3. Arcioni R, della Rocca M, Romanò S, Romano R,
Pietropaoli P, Gasparetto A. Ondansetron inhibits
the analgesic effects of tramadol: a possible
5-HT(3) spinal receptor involvement in acute
pain in humans. Anesth Analg 2002;94:1553-7.
4. Erhan E, Onal A, Kocabas S, Parlar A, Yegul I,
Kosay S. Ondansetron does not block tramadolinduced
analgesia in mice. Methods Find Exp
Clin Pharmacol 2005;27:629-32.
5. De Witte JL, Schoenmaekers B, Sessler DI, Deloof
T. The analgesic efficacy of tramadol is impaired
by concurrent administration of ondansetron.
Anesth Analg 2001;92:1319-21.
6. Tzeng JI, Chu KS, Ho ST, Cheng KI, Liu KS, Wang
JJ. Prophylactic iv ondansetron reduces nausea,
vomiting and pruritus following epidural morphine
for postoperative pain control. Can J Anaesth
2003;50:1023-6.
7. Petersen-Felix S, Arendt-Nielsen P, Bak P, et al.
Ondansetron does not inhibit the analgesic effect
of alfentanil. Br J Anaesth 1994;73:326-30.
8. Yoon MH, Bae HB, Choi JI, Kim SJ, Chung ST,
Kim CM. Lack of reciprocity between opioid
and 5-HT3 receptors for antinociception in rat
spinal cord. Pharmacology 2006;77:195-202.
9. Naesh O, Hindberg I, Christiansen C. Subarachnoid
bupivacaine increases human cerebrospinal
fluid concentration of serotonin. Reg
Anesth 1996;21:446-50.
10. Ye JH, Mui WC, Ren J, Hunt TE, Wu WH, Zbuzek
VK. Ondansetron exhibits the properties of a local
anesthetic. Anesth Analg 1997; 85:1116-21.
11. Glaum SR, Proudfit HK, Anderson EG. Reversal
of the antinociceptive effects of intrathecally
administered serotonin in the rat by a selective
5-HT3 receptor antagonist. Neurosci Lett
1988;95:313-7.
12. Alhaider AA, Lei SZ, Wilcox GL. Spinal 5-HT3
receptor-mediated antinociception: possible release
of GABA. J Neurosci 1991;11:1881- 8.
13. Giordano J, Schultea T. Serotonin 5-HT 3 receptor
mediation of pain and anti-nociception:
Implications for clinical therapeutics. Pain Physician
2004;7:141-7.
14. Cui M, Feng Y, McAdoo DJ, Willis WD. Periaqueductal
gray stimulation-induced inhibition of
nociceptive dorsal horn neurons in rats is associated
with the release of norepinephrine, serotonin,
and aminoacids. J Pharmacol Exp Ther
1999;289:868-76.
15. Sandrini M, Vitale G, Pini LA. Central antinociceptive
activity of acetylsalicylic acid is modulated
by brain serotonin receptor subtypes. Pharmacology
2002;65:193-7.
16. Hunt TE, Wu W, Zbuzek VK. Ondansetron blocks
nifedipine-induced analgesia in rats. Anesth
Analg 1996;82:498-500.
17. Mowafi HA, Arab SA, Ismail SA, Al-Ghamdi A.
The effects of intravenous granisetron on the
sensory and motor blockade produced by intrathecal
bupivacaine. Anesth Analg 2008;106:
1322-5.
303